Trial · NCT02558296
Results by group60
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 60
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in HbA1c From Baseline to Week 24 | Bexagliflozin Tablets, 20 mg | -0.85 | 95% Confidence Interval -0.90 to -0.80 | percentage of glycated hemoglobin | |
| Change in HbA1c From Baseline to Week 24 | Placebo Tablets | -0.37 | 95% Confidence Interval -0.44 to -0.30 | percentage of glycated hemoglobin | |
| Change From Baseline in HbA1c at Week 24 for Subjects Who Have Been Prescribed Insulin | Bexagliflozin Tablets, 20 mg | -0.84 | 95% Confidence Interval -0.92 to -0.77 | Percentage of HbA1c | |
| Change From Baseline in HbA1c at Week 24 for Subjects Who Have Been Prescribed Insulin | Placebo Tablets | -0.32 | 95% Confidence Interval -0.43 to -0.22 | Percentage of HbA1c | |
| Change in Body Weight From Baseline to Week 48 | Bexagliflozin Tablets, 20 mg | -3.03 | 95% Confidence Interval -3.27 to -2.80 | kg | |
| Change in Body Weight From Baseline to Week 48 | Placebo Tablets | -0.38 | 95% Confidence Interval -0.72 to -0.04 | kg | |
| Change in Systolic Blood Pressure From Baseline to Week 24 in Subjects Hypertensive at Baseline | Bexagliflozin Tablets, 20 mg | -9.83 | 95% Confidence Interval -11.28 to -8.38 | mm Hg | |
| Change in Systolic Blood Pressure From Baseline to Week 24 in Subjects Hypertensive at Baseline | Placebo Tablets | -6.87 | 95% Confidence Interval -8.95 to -4.78 | mm Hg | |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 6 | -0.69 | 95% Confidence Interval -0.72 to -0.65 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 6 | -0.24 | 95% Confidence Interval -0.28 to -0.19 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 12 | -0.89 | 95% Confidence Interval -0.94 to -0.85 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 12 | -0.34 | 95% Confidence Interval -0.39 to -0.28 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 24 | -0.84 | 95% Confidence Interval -0.89 to -0.79 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 24 | -0.37 | 95% Confidence Interval -0.45 to -0.30 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 36 | -0.86 | 95% Confidence Interval -0.92 to -0.81 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 36 | -0.39 | 95% Confidence Interval -0.47 to -0.32 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 48 | -0.84 | 95% Confidence Interval -0.90 to -0.79 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 48 | -0.38 | 95% Confidence Interval -0.46 to -0.30 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Bexagliflozin Tablets, 20 mg | Week 72 | -0.76 | 95% Confidence Interval -0.83 to -0.70 | Percentage of HbA1c |
| Change in HbA1c From Baseline Over Time | Placebo Tablets | Week 72 | -0.34 | 95% Confidence Interval -0.44 to -0.25 | Percentage of HbA1c |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02558296/results